In this video, Dr. Fizazi argues for treatment intensification for poor-prognosis germ cell tumor patients who display unfavorable marker decline.
Karim Fizazi, MD, PhD
Advertisement
Articles by Karim Fizazi, MD, PhD
Advertisement
Latest Updated Articles
PRO: Treatment Intensification in Poor Prognosis Germ Cell TumorsPublished: September 18th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
3
How Will the Continued Success of ADCs in Breast Cancer Be Propelled in the Future?
4
Neoadjuvant Nivolumab/Ipilimumab Shows Superior EFS in Resectable Melanoma
5
